Rola czynnika wzrostu śródbłonka naczyniowego w patogenezie łuszczycy

Rola czynnika wzrostu śródbłonka naczyniowego w patogenezie łuszczycy

Łuszczyca jest przewlekłą, nawrotową chorobą skóry charakteryzującąsię hiperplazją naskórka, stanem zapalnym związanym szczególniez odpowiedzią immunologiczną typu Th1 oraz zwiększoną ekspresjąwielu cytokin prozapalnych. Patogeneza łuszczycy jest związanamiędzy innymi z angiogenezą, czyli formowanie...

Full description

Bibliographic Details
Main Authors:	Bożena Chodynicka, Iwona Flisiak, Przemysław Zaniewski
Format:	Article
Language:	English
Published:	Termedia Publishing House 2011-01-01
Series:	Przegląd Dermatologiczny
Subjects:	VEGF VEGFR łuszczyca angiogeneza
Online Access:	http://www.termedia.pl/Rola-czynnika-wzrostu-srodblonka-naczyniowego-w-patogenezie-luszczycy,56,16045,1,0.html

Similar Items

Znaczenie adiponektyny w łuszczycy
by: Hanna Myśliwiec, et al.
Published: (2011-01-01)

Zastosowanie leków biologicznych w nietypowych postaciach łuszczycy – opis przypadków
by: Michał Rogowski-Tylman, et al.
Published: (2011-12-01)

Promieniowanie ultrafioletowe w leczeniu łuszczycy – przegląd badań = Ultraviolet radiation in the treatment of psoriasis - a review of research
by: Agnieszka Radzimińska, et al.
Published: (2015-07-01)

Rola VEGF, czynnika neurotroficznego i proangiogennego w patogenezie choroby Alzheimera
by: Marta Nowacka, et al.
Published: (2011-07-01)

Interleukina 12 jako mediator antyangiogenny u dzieci z cukrzycą typu 1
by: Katarzyna Zorena, et al.
Published: (2007-03-01)

An Investigation of Vascular Endothelial Growth Factor (VEGFR-1 and VEGFR-2) in Burn Wound Healing
by: L Abdulazeem, et al.
Published: (2022-04-01)

Rumień guzowaty u dziecka – opis przypadku
by: Bożena Chodynicka, et al.
Published: (2011-08-01)

Design and Synthesis of C-Terminal Modified Cyclic Peptides as VEGFR1 Antagonists
by: Lei Wang, et al.
Published: (2014-09-01)

VEGF as a Key Actor in Recurrent Respiratory Papillomatosis: A Narrative Review
by: Sandra Gazzini, et al.
Published: (2024-07-01)

Association study between the polymorphisms of angiogenesis‐related genes and cervical cancer susceptibility in Chinese Uygur population
by: Lili Han, et al.
Published: (2019-10-01)

Characterization of the Expression of Angiogenic Factors in Cutaneous Squamous Cell Carcinoma of Domestic Cats
by: Erwin Kristobal Gudenschwager-Basso, et al.
Published: (2022-07-01)

Establishment of an oral squamous cell carcinoma cell line expressing vascular endothelial growth factor a and its two receptors
by: Hanako Araki-Maeda, et al.
Published: (2022-10-01)

Evaluation of the toxicity and anti-angiogenic effects of beta-cyclodextrin complex loaded with thymol in melanoma skin cancer cells (A2058)
by: Mohadese Feyzmohamadi Khoramabadi, et al.
Published: (2024-08-01)

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
by: Lei Wang, et al.
Published: (2024-01-01)

Improved Wound Healing by Naringin Associated with MMP and the VEGF Pathway
by: Jia-Hau Yen, et al.
Published: (2022-03-01)

Role of VEGF-VEGFR2 signaling pathway in psoriasis
by: Xiaomei LUO, et al.
Published: (2022-10-01)

Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis
by: Megan Stevens, et al.
Published: (2019-03-01)

Rola polimorfizmu genu FTO w patogenezie otyłości
by: Włodzimierz Łuczyński, et al.
Published: (2010-06-01)

The VEGFs/VEGFRs system in Alzheimer’s and Parkinson’s diseases: Pathophysiological roles and therapeutic implications
by: Claudia Ceci, et al.
Published: (2024-03-01)

Breaking a Vicious Circle: Lymphangiogenesis as a New Therapeutic Target in Wound Healing
by: Filippo Renò, et al.
Published: (2023-02-01)

Prognostic significance of tumor angiogenesis markers in advanced cervical cancer undergoing chemotherapy
by: I Nyoman Bayu Mahendra, et al.
Published: (2024-12-01)

Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer
by: Niina Mäenpää, et al.
Published: (2024-03-01)

Vascular Endothelial Growth Factor: A Translational View in Oral Non-Communicable Diseases
by: Sven Niklander, et al.
Published: (2021-01-01)

Elements of the Endomucin Extracellular Domain Essential for VEGF-Induced VEGFR2 Activity
by: Zhengping Hu, et al.
Published: (2020-06-01)

YULINK regulates vascular formation in zebrafish and HUVECs
by: Hsin-Hung Lin, et al.
Published: (2023-02-01)

Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3
by: Ming-Chuan Hsu, et al.
Published: (2019-03-01)

VEGF-A, sVEGFR-1, and sVEGFR-2 in BCR-ABL negative myeloproliferative neoplasms
by: Grażyna Gadomska, et al.
Published: (2017-01-01)

Biomechanical stimulation promotes blood vessel growth despite VEGFR-2 inhibition
by: Bronte Miller Johnson, et al.
Published: (2023-12-01)

Genetic Polymorphisms in VEGFR Coding Genes (<i>FLT1</i>/<i>KDR</i>) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients
by: David Blánquez-Martínez, et al.
Published: (2022-07-01)

The mechanism of action and biodistribution of a novel EGFR/VEGF bispecific fusion protein that exhibited superior antitumor activities
by: Lan Deng, et al.
Published: (2023-06-01)

Expression of Diverse Angiogenesis Factor in Different Stages of the 4T1 Tumor as a Mouse Model of Triple-Negative Breast Cancer
by: Saba Malekian, et al.
Published: (2020-02-01)

Suramin Affects the Renal VEGF-A/VEGFR Axis in Short-Term Streptozotocin-Induced Diabetes
by: Gabriela Chyła-Danił, et al.
Published: (2023-03-01)

Soluble E-cadherin contributes to inflammation in acute lung injury via VEGF/VEGFR2 signaling
by: Lihong Yao, et al.
Published: (2025-02-01)

Successful treatment using apatinib in intractable brain edema: A case report and literatures review
by: Yanqiu Song, et al.
Published: (2018-12-01)

A case of primary pulmonary angiosarcoma arising from tuberculous scar with fatal capillary bleeding
by: Minghui Wang, et al.
Published: (2024-03-01)

Piceatannol, a Natural Analog of Resveratrol, Exerts Anti-angiogenic Efficiencies by Blockage of Vascular Endothelial Growth Factor Binding to Its Receptor
by: Wei-Hui Hu, et al.
Published: (2020-08-01)

Radiation therapy attenuates lymphatic vessel repair by reducing VEGFR-3 signalling
by: Vinochani Pillay, et al.
Published: (2023-04-01)

VEGF Stimulates Activation of ERK5 in the Absence of C-Terminal Phosphorylation Preventing Nuclear Localization and Facilitating AKT Activation in Endothelial Cells
by: Anil Kumar Mondru, et al.
Published: (2023-03-01)

Effect of endurance training on vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in tumor of breast cancer bearing mice
by: Elham Shahabpour, et al.
Published: (2018-08-01)

Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding
by: Maria V Gelfand, et al.
Published: (2014-09-01)